share_log

Chardan Capital Initiates Coverage On Zura Bio With Buy Rating, Announces Price Target of $14

Chardan Capital Initiates Coverage On Zura Bio With Buy Rating, Announces Price Target of $14

Chardan Capital以买入评级开始对Zura Bio的报道,宣布目标股价为14美元
Benzinga ·  2023/06/14 06:16

Chardan Capital analyst Matthew Barcus initiates coverage on Zura Bio (NASDAQ:ZURA) with a Buy rating and announces Price Target of $14.

Chardan Capital分析师马修·巴库斯以买入评级开始对祖拉生物(纳斯达克股票代码:ZURA)进行报道,并宣布目标股价为14美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发